Ion Channels
proteins that form ___ in the plasma membrane
categorized by:
- ___ opening and closing mechanism
- ion ___
- pharmacology
___ - allow ions to flow down their electrochemical gradient
pores
- gate
- selectivity
passive
Ion Channels and the Electrochemical Gradient
both
- concentration, electrical
Membrane Potential
excitable cells have a ___ inward potential across the membrane due to the selective permeability of the resting membrane to ___
negative, K+
Membrane Potential
K+
Na+
Ca2+
Membrane Potential
membrane potential is set by ___ permeability at rest
- note that ___ charged ions do not cross the membrane
K
- negatively
CCB
block channels in vascular smooth muscle: ___
- decrease in ___
- relief of ___
block of channels in cardiac muscle and SA/AV node: ___
vasodilation
- BP
- angina
antiarrhythmic
voltage gated Ca2+ channel family
cardiac, smooth muscle, Ca2+ entry triggers contraction
L-type
Cav 1.2
vascular smooth muscle contraction
Ca2+ influx via Cav 1.2 induces release of Ca2+ from ___ stores via ___ receptor in the SR
___ Ca2+ is required for contraction of cardiac and smooth muscle
B-adrenergic modulation Ca2+ channels
PKA phosphorylation of Cav1.2 increases Ca2+ ___
- increases contractility/force of contraction
- increases AV nodal action potential conduction rate
influx
T or F: extracellular Ca2+ is required for contraction of cardiac and vascular smooth muscle (not skeletal)
True
Cardiac Muscle Contraction
1) the Ca2+ ions released from the SR binds to ___
2) Ca2+ binding by ___ causes displacement of ___
3) displacement of ___ allows for ___ to bind actin
= CONTRACTION
Skeletal Muscle Contraction
Mechanical coupling between ___ and ___
CCBs
clincal applications: angina pectoris, arrhythmia, HTN
Three distinct chemical classes
1) dihydropyridines
2) phenylalkylamines
3) benzothiazepines
CCBs Dihydropyridines
dihydropyridine ring
aryl group
chiral center
ester linked side chains
CCBs Dihydropyridines
CCBs Dihydropyridines - Clevidipine (Cleviprex)
very rapid
CCBs Dihydropyridines
MOA: (+) enantiomer ___ current , (-) enatiomer ___ current
CCBs Dihydropyridines
tissue selectivity - more potent in relaxing smooth muscle, esp. ___
- do not compromise cardiac function
- not ___
- selectivity result of amino acid differences in channel splice variants, differences in membrane potential properties
coronary artery
antiarrhythmics
CCBs Dihydropyridines
characteristics of dihydropyridine block
- ___ dependence
- the ___ of drug for the channel is different at different voltages
voltage
affinity
CCBs Dihydropyridines
binding site is allosteric ( ___ of the pore_
- DHP drugs bind to closed channels and prevent opening - ___ block
CCBs Dihydropyridines
frequency
CCBs Dihydropyridines - Clinical Considerations
CCBs Dihydropyridines - Clinical Considerations
angina
nifedipine
atherosclerosis
serum proteins
amlodipine
T or F: prompt release nifedipine formulations may increase risk of subsequent heart attack
True
- rapid decrease in BP may lead to reflex sypathetic response tachycardia